Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
KYMR
PCVX
Add up to 3 more stocks
KYMR
Kymera Therapeutics, Inc.
-4.84%
$104.54-5.31Delayed quote: Oct 6, 2026, 1:40 PM EDT
Market Cap
$8.60B
52W Range
$55.26 - $130.05
PCVX
Vaxcyte, Inc.
-11.83%
$65.09-8.73Delayed quote: Oct 6, 2026, 1:35 PM EDT
Market Cap
$9.40B
52W Range
$39.87 - $90.75
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 5.70 | 3.41 |
| P/S Ratio | 81.90 | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 102.0% | 0.0% |
| Operating Margin | -891.3% | 0.0% |
| Net Margin | -285.4% | 0.0% |
| ROE | -19.9% | -38.6% |
| ROA | -18.2% | -33.9% |
| ROIC | -22.3% | -40.6% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 9.83 | 5.72 |
| Quick Ratio | N/A | 5.72 |
| Debt/Equity | 0.05 | 0.04 |
| Interest Coverage | -1403.21 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.